Impact of 18F-FDG PET/CT in the management decisions of breast cancer board on early-stage breast cancer.
Abdulselam ÖzdemirMustafa GüvenSerhat BiniciSerhat UygurOsman ToktasPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2023)
In conclusion, this study highlights the importance of adherence to the guidelines and appropriate use of PET/CT in early-stage breast cancer management. PET/CT should be reserved for cases where it is clinically warranted, considering the potential economic burden and minimal impact on treatment decisions of breast cancer tumor board in this patient population.